Abstract
As the number of patients and severity of conditions admitted to intensive care units have increased considerably over the past decade, so has the need and use of cardiovascular pharmacologic support. Over one-half of the more than 100 adult patients, who are occupying intensive care beds at any given time at The Ohio State University Medical Center, are being supported by intravenously administered cardiovascular-active drugs such as dopamine, dobutamine, nitroglycerin, and nitroprusside. Between 30–40% of our intensive care patients were taking orally administered cardiovascular-active drugs at the time of admission and/or will be receiving one or more of them during their stay in the intensive care unit; such agents include the nitrates, a vasodilator, a calcium channel blocking agent, and a converting enzyme inhibitor.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Leithe ME, Magorien RD, Hermiller JB, Unverferth DV, Leier CV (1984) Relationship between central hemodynamics and regional blood flow in normal subjects and in patients with congestive heart failure. Circulation 69:57–64
Wade OL, Bishop JM (1962) The distribution of the cardiac output in patients with heart disease. In : Wade OL, Bishop JM (eds) Cardiac output and regional blood flow. Blackwell Scientific, Oxford, pp 134–148
Leier CV (1986) Acute inotropic support: intravenously administered positive inotropic drugs. In: Leier CV (ed) Cardiotonic drugs. Dekker, New York, pp 49–84
Leier CV, Heban PT, Huss P, Bush CA, Lewis RP (1978) Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyo-pathic heart failure. Circulation 58:466–475
Leier CV (1988) Regional blood flow responses to vasodilators and inotropes in congestive heart failure. Am J Cardiol 62:86E–93E
Leier CV, Webel J, Bush CA (1977) The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure. Circulation 56:468–472
McDonald RH, Goldberg LI, McNay JL, Tuttle EP Jr (1964) Effects of dopamine in man: augmentation of sodium excretion, glomerular filtration rate, and renal plasma flow. J Clin Invest 43:1116–1124
Yeh BK, McNay JL, Goldberg LI (1969) Attenuation of dopamine renal and mesenteric vasodilation by haloperidol: evidence for a specific dopamine receptor. J Pharmacol Exp Ther 168:303–309
Leier CV, Binkley PF, Carpenter J, Randolph PH, Unverferth DV (1988) The cardiovascular pharmacology of dopexamine in patients with low output congestive heart failure. Am J Cardiol 62:94–99
Vincent JL, Reuse C, Kahn RJ (1989) Administration of dopexamine, a new adrenergic agent, in cardiorespiratory failure. Chest 96:1233–1236
Leier CV, Bambach D, Thompson MJ, Cattaneo SM, Goldberg RJ, Unverferth DV (1981) Central and regional hemodynamic effects of intravenous isosorbide dinitrate, nitroglycerin, and nitroprusside in patients with congestive heart failure. Am J Cardiol 48:1115–1123
Cogan JJ, Humphreys MH, Carlson CJ, Rapaport E (1980) Renal effects of nitroprusside and hydralazine in patients with congestive heart failure. Circulation 61:316–323
Leier CV (1985) Nitrate tolerance. Am Heart J 110:224–232
Leier CV, Magorien RD, Desch CE, Thompson MJ, Unverferth DV (1981) Hydralazine and isosorbide dinitrate: comparative central and regional hemodynamic effects when administered alone or in combination. Circulation 63:102–109
Magorien RD, Triffon DW, Desch CE, Bay WH, Unverferth DV, Leier CV (1981) Prazosin and hydralazine in congestive heart failure: regional hemodynamic effects in relation to dose. Ann Intern Med 95:5–13
Leier CV, Patrick TJ, Hermiller JB, Pacht KD, Huss P, Magorien RD, Unverferth DV (1984) Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow. Am Heart J 108:1461–1468
Elkayam U, Weber L, Massry SG, Rahimtoola SH (1984) Renal hemodynamic effects of vasodilatation with nifedipine and hydralazine in patients with heart failure. J Am Coll Cardiol 4:1261–1267
Creager MA, Halperin JL, Bernard DB, et al. (1981) Acute regional circulatory and renal hemodynamic effects of converting enzyme inhibition in patients with congestive heart failure. Circulation 64:483–489
Levine TB, Olivan MT, Garberg U, Sharkey SW, Cohn JN (1984) Hemodynamic and clinical response to enalapril, a long-acting converting enzyme inhibitor, in patients with congestive heart failure. Circulation 69:548–553
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin, Heidelberg
About this paper
Cite this paper
Leier, C.V. (1991). Effects of Therapy on Regional Blood Flow in Heart Failure. In: Vincent, J.L. (eds) Update 1991. Update in Intensive Care and Emergency Medicine, vol 14. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84423-2_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-84423-2_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-53672-7
Online ISBN: 978-3-642-84423-2
eBook Packages: Springer Book Archive